Ensysce Presents "A New Generation of Safer Pain Treatments"
~ Leading Experts Presenting New Clinical Approaches to Treat Severe Pain at PAINWeek Symposium ~ SAN DIEGO, CA / ACCESSWIRE / September 7, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to improve prescription drug safety, is presenting clinical data at PAINWeek, the leading US pain conference, today, September 7, 2023, in Las Vegas, NV. America remains...
Read more









